文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基因沉默对转移性肾癌细胞系ACHN 细胞周期和凋亡的影响。

Effects of gene silencing on cell cycle and apoptosis in the metastatic renal carcinoma cell line ACHN.

机构信息

Department of Urology Surgery, 66562Affiliated Zhongshan Hospital of Dalian University, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning Province, China.

出版信息

J Int Med Res. 2022 Feb;50(2):3000605221075511. doi: 10.1177/03000605221075511.


DOI:10.1177/03000605221075511
PMID:35118889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8819771/
Abstract

OBJECTIVE: To explore the role of high mobility group AT-hook 2 (HMGA2) in the regulation of the cell cycle and apoptosis. METHODS: The renal carcinoma cell line ACHN was transiently transfected with small interfering RNA to knock down the expression of the gene. Cell cycle analysis was undertaken using flow cytometry. The mRNA and protein levels of HMGA2, E2F transcription factor 1 (E2F1), cyclin D1, cyclin dependent kinase 6 (CDK6), B-cell lymphoma-2 (Bcl-2), caspase-3 and caspase-9 were analysed using reverse transcription quantitative real-time polymerase chain reaction and Western blot analysis. RESULTS: The mRNA and protein levels of HMGA2 were significantly higher in renal carcinoma cell lines compared with the human renal proximal tubular epithelial cell line HKC. After gene-specific silencing, more cells entered the G/G phase, while fewer cells entered the G/M phase; and the cells exhibited early and late apoptosis. gene-specific silencing significantly reduced the mRNA and protein levels of E2F1, cyclin D1, CDK6 and Bcl-2; and increased the mRNA and protein levels of caspase-3 and caspase-9. CONCLUSION: The gene may be involved in the tumorigenesis and development of renal cancer, thus inhibiting gene expression might provide a potential therapeutic target in the future.

摘要

目的:探讨高迁移率族蛋白 A2(HMGA2)在细胞周期和凋亡调控中的作用。

方法:采用小干扰 RNA 瞬时转染肾癌细胞系 ACHN,敲低基因的表达。采用流式细胞术进行细胞周期分析。采用逆转录定量实时聚合酶链反应和 Western blot 分析检测 HMGA2、E2F 转录因子 1(E2F1)、细胞周期蛋白 D1(cyclin D1)、细胞周期蛋白依赖性激酶 6(CDK6)、B 细胞淋巴瘤-2(Bcl-2)、半胱天冬酶-3 和半胱天冬酶-9 的 mRNA 和蛋白水平。

结果:与人类肾近端小管上皮细胞系 HKC 相比,肾癌细胞系中 HMGA2 的 mRNA 和蛋白水平显著升高。基因特异性沉默后,更多的细胞进入 G0/G1 期,而进入 G2/M 期的细胞减少;并且细胞表现出早晚期凋亡。基因特异性沉默显著降低了 E2F1、cyclin D1、CDK6 和 Bcl-2 的 mRNA 和蛋白水平;并增加了 caspase-3 和 caspase-9 的 mRNA 和蛋白水平。

结论:基因可能参与了肾癌的发生和发展,因此抑制基因表达可能为未来提供一个潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eca/8819771/4bfec189c64c/10.1177_03000605221075511-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eca/8819771/5786766c36ae/10.1177_03000605221075511-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eca/8819771/27071f5d2e73/10.1177_03000605221075511-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eca/8819771/4bfec189c64c/10.1177_03000605221075511-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eca/8819771/5786766c36ae/10.1177_03000605221075511-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eca/8819771/27071f5d2e73/10.1177_03000605221075511-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eca/8819771/4bfec189c64c/10.1177_03000605221075511-fig3.jpg

相似文献

[1]
Effects of gene silencing on cell cycle and apoptosis in the metastatic renal carcinoma cell line ACHN.

J Int Med Res. 2022-2

[2]
Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells.

Mol Med Rep. 2017-8-16

[3]
Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells.

Mol Vis. 2012

[4]
siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.

J Gastrointest Cancer. 2017-6

[5]
Effects of HMGA2 on the epithelial-mesenchymal transition-related genes in ACHN renal cell carcinoma cells-derived xenografts in nude mice.

BMC Cancer. 2022-4-19

[6]
Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells.

World J Gastroenterol. 2013-2-28

[7]
miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.

Mol Med Rep. 2018-2-8

[8]
HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.

Oncol Rep. 2017-11-10

[9]
HMGA2 gene is a promising target for ovarian cancer silencing therapy.

Int J Cancer. 2008-7-15

[10]
[The effects of lentivirus-mediated RNA interference silencing HMGA2 on proliferation and expressions of cyclin B2 and cyclin A2 in HL-60 cells].

Zhonghua Xue Ye Xue Za Zhi. 2012-6

引用本文的文献

[1]
Resveratrol Downregulated PRDX4 Expression to Inhibit the Progression of Renal Cell Carcinoma via Wnt/β-Catenin Pathway.

Food Sci Nutr. 2025-6-1

[2]
Decoding high mobility group A2 protein expression regulation and implications in human cancers.

Discov Oncol. 2024-7-31

[3]
Significance of High-Mobility Group A Protein 2 Expression in Pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma.

Turk J Gastroenterol. 2023-10

[4]
Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity.

Cancers (Basel). 2023-5-17

[5]
An Overview of siRNA Delivery Strategies for Urological Cancers.

Pharmaceutics. 2022-3-27

本文引用的文献

[1]
Restoration of MiR-34a Expression by 5-Azacytidine Augments Alimta -Induced Cell Death in Non-Small Lung Cancer Cells by Downregulation of HMG B1, A2 and Bcl-2 Pathway.

Cell J. 2021-11

[2]
CDK13-Mediated Cell Cycle Disorder Promotes Tumorigenesis of High HMGA2 Expression Gastric Cancer.

Front Mol Biosci. 2021-8-26

[3]
Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression.

J Cancer Res Clin Oncol. 2021-11

[4]
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials.

Eur J Cancer. 2021-9

[5]
Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma.

Front Oncol. 2021-4-28

[6]
A Review of Recent Research on the Role of MicroRNAs in Renal Cancer.

Med Sci Monit. 2021-5-8

[7]
The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments.

Cancers (Basel). 2021-4-25

[8]
Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma.

Front Immunol. 2021

[9]
Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials.

Eur Urol Focus. 2022-3

[10]
HMGA2 as a Critical Regulator in Cancer Development.

Genes (Basel). 2021-2-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索